Clinical features and cancer risk in families with pathogenicCDH1variants irrespective of clinical criteria
Open Access
- 11 July 2019
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 56 (12) , 838-843
Abstract
Background: The clinical phenotype ofCDH1pathogenic variant carriers has mostly been studied in families that fulfil criteria of hereditary diffuse gastric cancer (HDGC). We aimed at determining cancer phenotype and cancer risk estimation among families withCDH1pathogenic variants not selected by HDGC clinical criteria.Methods: Patients were all consecutively identifiedCDH1pathogenic variant carriers from a clinical laboratory tested with multigene panel testing and from an academic cancer genetics programme. Clinical and demographic features, cancer phenotypes and genotype–phenotype correlations were determined amongCDH1families. Age-specific cumulative cancer risks (penetrance) were calculated based on 38 families with available pedigrees.Results: Within the 113CDH1pathogenic variant probands and 476 relatives, 113 had gastric cancer, 177 breast cancer and 196 other cancers. Mean age at diagnosis was 47 for gastric and 54 for breast cancer. Forty-six per cent fulfilled criteria of HDGC. While 36% of families had both gastric and breast cancers, 36% had breast but no gastric cancers and 16% had gastric but not breast cancers. Cumulative risk of cancer by age 80 was 37.2% for gastric and 42.9% for breast cancer.Conclusion: In unselectedCDH1pathogenic variant carrier families, gastric cancer risks were lower and age at diagnosis higher than previously reported in families pre-selected for HDGC criteria. A substantial proportion of families did not present with any gastric cancers and their cancers were limited to breast. Thus, clinical criteria forCDH1testing should be widened, including breast cancer families only, and a consideration for delayed prophylactic gastrectomy/surveillance should be evaluated.Keywords
Funding Information
- Prevent Cancer Foundation
- Yale University Cancer Center
This publication has 20 references indexed in Scilit:
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Gene of the month: E-cadherin ( CDH1 )Journal of Clinical Pathology, 2013
- Mendel: the Swiss army knife of genetic analysis programsBioinformatics, 2013
- Comparison of a Lymph Node Ratio–Based Staging System With the 7th AJCC System for Gastric CancerAnnals of Surgery, 2012
- Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future researchJournal of Medical Genetics, 2010
- Prophylactic Total Gastrectomy (PTG) for Hereditary Diffuse Gastric Cancer (HDGC): The Newfoundland Experience with 23 PatientsAnnals of Surgical Oncology, 2009
- Germline CDH1 deletions in hereditary diffuse gastric cancer familiesHuman Molecular Genetics, 2009
- Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric CancerJAMA, 2007
- Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancerJournal of Medical Genetics, 2005
- Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindredHuman Mutation, 2002